Actually, Many New Cancer Drugs May Be Helpful And Worth Trying Actually, Many New Cancer Drugs May Be Helpful And Worth Trying
A Pill Might Control Pancreatic Cancer, Even If It Doesn’t Cure It A Pill Might Control Pancreatic Cancer, Even If It Doesn’t Cure It
Precision Oncology Drug Shows Power Of Cancer Genomics Precision Oncology Drug Shows Power Of Cancer Genomics
Encouraging Results For Ribociclib In Advanced Breast Cancer Encouraging Results For Ribociclib In Advanced Breast Cancer
Tragedy In A Clinical Trial: A Reminder That Biotech Is Not A Game Tragedy In A Clinical Trial: A Reminder That Biotech Is Not A Game
A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer
The Emerging Value Of Personalized Phase 1 Clinical Trials In Oncology The Emerging Value Of Personalized Phase 1 Clinical Trials In Oncology
MammaPrint, Agendia’s Breast Cancer Test, Is Having A U.S. Moment. Can It Reduce Overtreatment? MammaPrint, Agendia’s Breast Cancer Test, Is Having A U.S. Moment. Can It Reduce Overtreatment?
Could New Lung Cancer Meds Keep Walter White From Breaking Bad? Could New Lung Cancer Meds Keep Walter White From Breaking Bad?
Companion Diagnostics? For Cancer Care, We Need Better Ones Companion Diagnostics? For Cancer Care, We Need Better Ones
Precision Medicine Is A Needed Goal That Will Benefit Cancer Patients Precision Medicine Is A Needed Goal That Will Benefit Cancer Patients
Precision Medicine Will (Eventually) Lower Cancer Care Costs Precision Medicine Will (Eventually) Lower Cancer Care Costs
Why Evidence From A Clinical Trial Of Ovarian Cancer Has Limited Value Why Evidence From A Clinical Trial Of Ovarian Cancer Has Limited Value
Can Journalists Be Too Skeptical About Progress Against Cancer? Can Journalists Be Too Skeptical About Progress Against Cancer?
On The Death Of Beau Biden, Brain Cancer, Progress And Hope On The Death Of Beau Biden, Brain Cancer, Progress And Hope
Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors
Thinking Ahead: From ‘The Emperor Of All Maladies’ To Precision Medicine In Cancer Thinking Ahead: From ‘The Emperor Of All Maladies’ To Precision Medicine In Cancer
Chatting With Anne Parker: A Patient’s View On How Cancer Care Has Changed Since The 1960s Chatting With Anne Parker: A Patient’s View On How Cancer Care Has Changed Since The 1960s
On The Death Of David Carr, And Cancer Survivorship On The Death Of David Carr, And Cancer Survivorship
Novel Drug Expands Treatment Options For Women With Metastatic Breast Cancer Novel Drug Expands Treatment Options For Women With Metastatic Breast Cancer
Why The FDA Panel’s Nod To Sandoz’s Filgrastim (Zarzio) Is Good News For Patients Why The FDA Panel’s Nod To Sandoz’s Filgrastim (Zarzio) Is Good News For Patients
What’s Intriguing And Concerning About Early Results For Keytruda In Breast Cancer What’s Intriguing And Concerning About Early Results For Keytruda In Breast Cancer
For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy
At Palliative Care In Oncology Symposium, A Burst Of Energy At Palliative Care In Oncology Symposium, A Burst Of Energy
Perjeta Works In A Form Of Metastatic Breast Cancer: Active In Other Tumors? Perjeta Works In A Form Of Metastatic Breast Cancer: Active In Other Tumors?
The (Unmet) Potential Value of Cancer Genome Testing The (Unmet) Potential Value of Cancer Genome Testing
Breast Cancer Chemotherapy Varies Widely: Study Raises Questions About Early Treatment Choices Breast Cancer Chemotherapy Varies Widely: Study Raises Questions About Early Treatment Choices
Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer
